How to study ‘building blocks’ of behavior

Researchers at Vanderbilt have been able to alter mouse behavior by silencing gene expression in interneurons, distinct populations of nerve cells that are the main regulators of brain circuits. Interneurons can be thought of as the “building blocks” to impact behavior. Researchers found that changing the expression of a gene in one interneuron population had the exact opposite molecular and behavioral effect compared to changing the same gene in another.  

Morning Report: VPH Adult Psychiatry

Morning Report in Psychiatry at the Vanderbilt Psychiatric Hospital was originally developed by Dr. Stephan Heckers and Dr. Harsh Trivedi in 2009 as a means of communicating good clinical handover from patients seen during the Night Float rotation to the daytime teams.  Over the years, the scope of the handover has dramatically increased to include an effective clinical handover as well as administrative reports (number of patients seen overnight, anticipated discharges, etc).   

Speaking Up About an Uncomfortable Condition

Bowels, especially those that don’t function properly, are not a popular topic of conversation. Most of the 1.4 million Americans with inflammatory bowel disease — Crohn’s disease or ulcerative colitis — suffer in silence. But scientists are making exciting progress in understanding the causes of these conditions and in developing more effective therapies. And affected individuals have begun to speak up to let others know that they are not alone.

A Storm Within

Recognizing the signs of a brewing anxiety disorder Sixteen-year-old Hannah is a picture-perfect Middle Tennessee teenager. A straight-A student, beautiful, active and musically talented, she starred in her high school’s spring musical. Hannah (not her real name) hid a brewing anxiety disorder so well that even her mother had no idea she was becoming incapacitated by it—until she came home from a movie with her boyfriend last spring and quietly said that she had thought about committing suicide that night.

Brain-gut connection in autism

Gastrointestinal (GI) symptoms are a common source of distress in children with autism spectrum disorder (ASD), but the relationship between GI symptoms and autism-related behavior is unclear. Clinical experience suggested to Brittany Peters, M.D., Jeremy Veenstra-VanderWeele, M.D., and colleagues that rigid-compulsive behaviors are associated with severe constipation and co-occurring diarrhea or underwear staining in children with ASD.

Program takes new approach to pain management

Patients with chronic pain who are covered by the Vanderbilt Employee Health Care Plan or workers’ compensation system can now enroll in an innovative rehabilitation program that could dramatically change how chronic pain is treated.

Theatre offers promise for youth with autism, Vanderbilt study finds

A novel autism intervention program using theatre to teach reciprocal communication skills is improving social deficits in adolescents with the disorder that now affects an estimated one in 88 children, Vanderbilt University researchers released today in the journal Autism Research.

Vanderbilt scientists discover potential new way to treat anxiety

Chemically modified inhibitors of the COX-2 enzyme relieve anxiety behaviors in mice by activating natural “endocannabinoids” without gastrointestinal side effects, Vanderbilt University scientists will report next week. Endocannabinoids are natural signaling molecules that activate cannabinoid receptors in the brain, the same receptors turned on by the active ingredient in marijuana.  

Antipsychotic drug use in children for mood/behavior disorders increases type 2 diabetes risk

Prescribing of “atypical” antipsychotic medications to children and young adults with behavioral problems or mood disorders may put them at unnecessary risk for type 2 diabetes, a Vanderbilt University Medical Center study shows. Young people using medications like risperidone, quetiapine, aripiprazol and olanzapine led to a threefold increased risk of developing type 2 diabetes within the first year of taking the drug, according to the study published Aug. 21 in the journal JAMA Psychiatry.